Skip to content

Drug interactions

Belumosudil + Eslicarbazepine

Severity: Moderate

Belumosudil and Eslicarbazepine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a weak-to-moderate inducer of CYP3A4 and may lower belumosudil exposure. Reduced exposure could weaken the treatment effect in chronic graft-versus-host disease.

What this interaction means in plain words

Belumosudil and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Belumosudil belongs to Oncology; Eslicarbazepine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Induction of CYP3A4 by eslicarbazepine increases the metabolic clearance of belumosudil.

What to do

Monitor for loss of response to belumosudil in chronic GVHD. Consider an alternative anticonvulsant without enzyme-inducing activity if response declines.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belumosudil and Eslicarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belumosudil with Eslicarbazepine?

MediHelp rates the interaction as moderate. Belumosudil and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine is a weak-to-moderate inducer of CYP3A4 and may lower belumosudil exposure. Reduced exposure could weaken the treatment effect in chronic graft-versus-host disease.

How serious is the interaction between Belumosudil and Eslicarbazepine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of response to belumosudil in chronic GVHD. Consider an alternative anticonvulsant without enzyme-inducing activity if response declines.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in